NCT00733980 - A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

October 2, 2008

Primary Completion Date

June 18, 2010

Study Completion Date

June 18, 2010

Conditions

Depressive Disorder, Major

Interventions

DRUG

GSK561679

OTHER

Placebo

Trial Locations (18)

19104

GSK Investigational Site, Philadelphia

20852

GSK Investigational Site, Rockville

27609

GSK Investigational Site, Raleigh

30060

GSK Investigational Site, Marietta

30322

GSK Investigational Site, Atlanta

32216

GSK Investigational Site, Jacksonville

33125

GSK Investigational Site, Miami

38119

GSK Investigational Site, Memphis

53223

GSK Investigational Site, Brown Deer

53719

GSK Investigational Site, Madison

60076

GSK Investigational Site, Skokie

60612

GSK Investigational Site, Chicago

71104

GSK Investigational Site, Shreveport

87109

GSK Investigational Site, Albuquerque

90502

GSK Investigational Site, Torrance

90703

GSK Investigational Site, Cerritos

92108

GSK Investigational Site, San Diego

45219-0516

GSK Investigational Site, Cincinnati